Literature DB >> 7860757

The effects of non-insulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues.

D Turk1, A Alzaid, S Dinneen, K S Nair, R Rizza.   

Abstract

The mechanism(s) of insulin resistance in non-insulin-dependent diabetes mellitus remains ill defined. The current studies sought to determine whether non-insulin-dependent diabetes mellitus is associated with (a) a delay in the rate of onset of insulin action, (b) impaired hepatic and extrahepatic kinetic responses to insulin, and (c) an alteration in the contribution of gluconeogenesis to hepatic glucose release. To answer these questions, glucose disappearance, glucose release, and the rate of incorporation of 14CO2 into glucose were measured during 0.5 and 1.0 mU/kg-1 per min-1 insulin infusions while glucose was clamped at approximately 95 mg/dl in diabetic and nondiabetic subjects. The absolute rate of disappearance was lower (P < 0.05) and the rate of increase slower (P < 0.05) in diabetic than nondiabetic subjects during both insulin infusions. In contrast, the rate of suppression of glucose release in response to a change in insulin did not differ in the diabetic and nondiabetic subjects during either the low (slope 30-240 min:0.02 +/- 0.01 vs 0.02 +/- 0.01) or high (0.02 +/- 0.00 vs 0.02 +/- 0.00) insulin infusions. However, the hepatic response to insulin was not entirely normal in the diabetic subjects. Both glucose release and the proportion of systemic glucose being derived from 14CO2 (an index of gluconeogenesis) was inappropriately high for the prevailing insulin concentration in the diabetic subjects. Thus non-insulin-dependent diabetes mellitus slows the rate-limiting step in insulin action in muscle but not liver and alters the relative contribution of gluconeogenesis and glycogenolysis to hepatic glucose release.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7860757      PMCID: PMC295544          DOI: 10.1172/JCI117723

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  48 in total

Review 1.  Assessment of insulin sensitivity in vivo.

Authors:  R N Bergman; D T Finegood; M Ader
Journal:  Endocr Rev       Date:  1985       Impact factor: 19.871

2.  Pathways of carbon flux in gluconeogenesis.

Authors:  J T Brosnan
Journal:  Fed Proc       Date:  1982-01

3.  Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects.

Authors:  C Bogardus; S Lillioja; B V Howard; G Reaven; D Mott
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

4.  Initial splanchnic extraction of ingested glucose in normal man.

Authors:  J Radziuk; T J McDonald; D Rubenstein; J Dupre
Journal:  Metabolism       Date:  1978-06       Impact factor: 8.694

5.  A peroxidase-coupled method for the colorimetric determination of serum triglycerides.

Authors:  M W McGowan; J D Artiss; D R Strandbergh; B Zak
Journal:  Clin Chem       Date:  1983-03       Impact factor: 8.327

6.  Insulin receptors in human endothelial cells: identification and characterization.

Authors:  R S Bar; J C Hoak; M L Peacock
Journal:  J Clin Endocrinol Metab       Date:  1978-09       Impact factor: 5.958

7.  Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus.

Authors:  O G Kolterman; R S Gray; J Griffin; P Burstein; J Insel; J A Scarlett; J M Olefsky
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

8.  Practical closed-loop insulin delivery. A system for the maintenance of overnight euglycemia and the calculation of basal insulin requirements in insulin-dependent diabetics.

Authors:  N H White; D Skor; J V Santiago
Journal:  Ann Intern Med       Date:  1982-08       Impact factor: 25.391

9.  Delayed onset of insulin activation of the insulin receptor kinase in vivo in human skeletal muscle.

Authors:  G R Freidenberg; S Suter; R R Henry; J Nolan; D Reichart; J M Olefsky
Journal:  Diabetes       Date:  1994-01       Impact factor: 9.461

10.  Dose-response characteristics for effects of insulin on production and utilization of glucose in man.

Authors:  R A Rizza; L J Mandarino; J E Gerich
Journal:  Am J Physiol       Date:  1981-06
View more
  10 in total

1.  Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene.

Authors:  L Rossetti; A E Stenbit; W Chen; M Hu; N Barzilai; E B Katz; M J Charron
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

Review 2.  Insulin resistance in non-insulin-dependent diabetes mellitus. A review.

Authors:  A A Alzaid
Journal:  Acta Diabetol       Date:  1996-07       Impact factor: 4.280

Review 3.  The role of endothelial insulin signaling in the regulation of glucose metabolism.

Authors:  Tetsuya Kubota; Naoto Kubota; Takashi Kadowaki
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

Review 4.  Use of dicarboxylic acids in type 2 diabetes.

Authors:  Geltrude Mingrone; Lidia Castagneto-Gissey; Katherine Macé
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

5.  Whole-body proteolysis rate is elevated in HIV-associated insulin resistance.

Authors:  Dominic N Reeds; W Todd Cade; Bruce W Patterson; William G Powderly; Samuel Klein; Kevin E Yarasheski
Journal:  Diabetes       Date:  2006-10       Impact factor: 9.461

Review 6.  The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action.

Authors:  E J Barrett; E M Eggleston; A C Inyard; H Wang; G Li; W Chai; Z Liu
Journal:  Diabetologia       Date:  2009-03-13       Impact factor: 10.122

7.  The Lx1 gene maps to mouse chromosome 17 and codes for a protein that is homologous to glucose and polyspecific transmembrane transporters.

Authors:  N Schweifer; D P Barlow
Journal:  Mamm Genome       Date:  1996-10       Impact factor: 2.957

8.  Pioglitazone increases whole body insulin sensitivity in obese, insulin-resistant rhesus monkeys.

Authors:  Effie Tozzo; Gowri Bhat; Kyeongmi Cheon; Raul C Camacho
Journal:  PLoS One       Date:  2015-05-08       Impact factor: 3.240

9.  Pioglitazone decreases fasting and postprandial endogenous glucose production in proportion to decrease in hepatic triglyceride content.

Authors:  Balasubramanian Ravikumar; Jean Gerrard; Chiara Dalla Man; Michael J Firbank; Annette Lane; Philip T English; Claudio Cobelli; Roy Taylor
Journal:  Diabetes       Date:  2008-06-05       Impact factor: 9.461

10.  Accurate Measurement of Postprandial Glucose Turnover: Why Is It Difficult and How Can It Be Done (Relatively) Simply?

Authors:  Robert A Rizza; Gianna Toffolo; Claudio Cobelli
Journal:  Diabetes       Date:  2016-05       Impact factor: 9.461

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.